ID   Shef-UPS 04
AC   CVCL_C8VI
SY   Shef-UPS04; STS 13/12; Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 04
DR   Wikidata; Q123033491
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 43.49 hours (Direct_author_submission).
CC   Miscellaneous: Age/sex of donor, STR profile, doubling time and sampling site from personal communication of Birkett, Ashley J.
CC   Derived from site: In situ; Leg, hypodermis; UBERON=UBERON_0000978+UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 31.2,33.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
RX   PubMed=29853780; DOI=10.1155/2018/3082526; PMCID=PMC5964616;
RA   Salawu A., Wright K., Al-Kathiri A., Wyld L., Reed M.W.R., Sisley K.;
RT   "Sister chromatid exchange and genomic instability in soft tissue
RT   sarcomas: potential implications for response to DNA-damaging
RT   treatments.";
RL   Sarcoma 2018:3082526.1-3082526.8(2018).
//